1 The effects of the antiarrhythmic drug flecainide on levcromakalim-induce
d hyperpolarization, macroscopic and unitary K+ currents in pig urethra wer
e investigated using patch-clamp techniques. The effects of flecainide were
also examined on currents in inside-out patches of COS7 cells expressing c
arboxy terminus truncated inwardly rectifying K+ channel (Kir6.2) subunits
(i.e. Kir6.2 Delta C36) which form ATP-sensitive K+ channels (K-ATP channel
s).
2 In current-clamp mode, application of flecainide (greater than or equal t
o 100 muM) caused a significant depolarization after the membrane potential
had been hyperpolarized by levcromakalim.
3 In voltage-clamp experiments, the levcromakalim-induced outward current w
as suppressed by 300 muM flecainide in quasi-physiological K+ conditions(K-
i=51 muM). In contrast, approximately 20% of the levcromakalim-induced inwa
rd current still remained even after application of 300 muM flecainide in s
ymmetrical 140 mM K+ conditions (K-i=126 muM).
4 In cell-attached configuration, the channel activity of the levcromakalim
-induced K-ATP channels was reversibly inhibited by flecainide (greater tha
n or equal to 30 muM) at -50 mV. Their activity was also suppressed by eith
er disopyramide or cibenzoline.
5 Flecainide reversibly inhibited the channel activity of Kir6.2 Delta C36
expressed in COS7 cells using inside-out configuration.
6 Inhibitory effects of flecainide on the levcromakalim-induced currents be
came more potent when the value of external pH increased, although this sli
ghtly reduced the proportion of drug molecules carrying a positive charge.
7 These results suggest that flecainide inhibits channel activity through b
locking the pore site of the K-ATP channel in pig urethra.